GRI Bio, Inc. (GRI) Stock price, Description, News & Info

#ThinkSabio Latest News

GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)